| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | BMS-345541 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | 0.34 | 0.05 |
| mRNA | TL-2-105 | GDSC1000 | pan-cancer | AAC | 0.063 | 0.05 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.32 | 0.05 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.1 | 0.05 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.33 | 0.05 |